Controlled potassium reduction using dialysate profiling in hyperkalemic hemodialysis patients: A randomized study.

Area of Science:

• Nephrology
• Cardiology
• Clinical Trials

Background:

• Dialysate potassium concentration in hemodialysis for hyperkalemia is debated.
• Low-potassium dialysate enhances potassium removal but may increase arrhythmia risk.
• This study evaluated a two-phase dialysate potassium profiling strategy.

Purpose of the Study:

• To assess the efficacy of a two-phase dialysate potassium profiling strategy.
• To compare potassium removal and arrhythmia incidence between two dialysate strategies.
• To determine the optimal dialysate potassium approach for hyperkalemic hemodialysis patients.

Main Methods:

• Randomized controlled trial involving 60 end-stage renal disease patients with hyperkalemia.
• Group A: 2 mEq/L potassium dialysate for 1 hour, then 0 mEq/L for 3 hours.
• Group B: Constant 2 mEq/L potassium dialysate for 4 hours; cardiac arrhythmias monitored.

Main Results:

• Group A achieved significantly lower post-dialysis serum potassium (3.48 ± 0.22 mEq/L) compared to Group B (3.72 ± 0.42 mEq/L; p=0.008).
• Both groups had similar, low rates of cardiac arrhythmias (one case of ventricular ectopy each).
• Patient demographics indicated high cardiovascular risk (diabetes, hypertension).

Conclusions:

• Two-phase dialysate potassium profiling is more effective in lowering serum potassium than a fixed approach.
• This strategy does not significantly increase the risk of cardiac arrhythmias.
• Two-phase profiling is a safe and effective option for managing hyperkalemia in hemodialysis.